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Stimulation of the B cell antigen receptor (BCR) triggers signaling pathways that promote the
differentiation of B cells into plasma cells. Despite the pivotal function of BCR in B cell
activation, the organization of the BCR on the surface of resting and antigen-activated B cells
remains unclear. Here we show, using STED super-resolution microscopy, that IgM-
containing BCRs exist predominantly as monomers and dimers in the plasma membrane
of resting B cells, but form higher oligomeric clusters upon stimulation. By contrast, a chronic
lymphocytic leukemia-derived BCR forms dimers and oligomers in the absence of a stimulus,
but a single amino acid exchange reverts its organization to monomers in unstimulated
B cells. Our super-resolution microscopy approach for quantitatively analyzing cell surface
proteins may thus help reveal the nanoscale organization of immunoreceptors in various
cell types.
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The characterization of the molecular arrangement ofimmunoreceptors on the cell surface has been hampered inthe past by the lack of powerful imaging techniques that
allow visualization and quantiﬁcation of the entire pool of native
receptor complexes within the plasma membrane in an unbiased
manner. Thus, our knowledge on the structural organization of
antigen receptors in lymphocytes is largely based on biochemical
data and indirect visualization methods. Recent progress in the
ﬁeld of super-resolution microscopy now allows imaging and
direct analysis of native receptors on the cell surface1.
The conception of the molecular composition and spatial
organization of the B cell antigen receptor (BCR) has changed
considerably over time. Traditionally it was assumed that a fully
assembled BCR complex adopts a symmetrical structure, in which
one membrane-bound immunoglobulin (mIg) molecule makes
non-covalent contacts to two copies of the signal-initiating Igα/
Igβ (CD79A/B) heterodimer of transmembrane proteins2–4. Yet,
when this model was put to the test it turned out that mIg and
Igα/β are present in a 1:1 stoichiometry on the cell surface5,6.
Another traditional assumption implied that BCR complexes
consisting of mIg and Igα/β exist as ‘monomeric units’ on the cell
surface of resting B cells. However, this view has been challenged
in recent years by reports providing some clues that BCR units
may form higher, oligomeric clusters in the plasma membrane
of resting B cells, i.e., already in the absence of antigenic stimu-
lation7–9 These observations are based on experiments using
indirect visualization methods like bimolecular ﬂuorescence
complementation (BiFC) or proximity ligation assay (PLA)
aiming at determining the distance between individual BCR
components (such as the mIg portion) or their capability to come
into close proximity in the absence of antigen7,8. Furthermore,
imaging experiments using direct stochastic optical reconstruc-
tion microscopy (dSTORM) indicated the existence of oligomeric
BCRs containing several dozens of ‘monomeric units’ within so-
called protein islands in the plasma membrane9–11. Based on
these ﬁndings, it was proposed that the activation of intracellular
signaling cascades following BCR stimulation requires the open-
ing or dissociation of preformed BCR oligomers, which would
expose the otherwise inaccessible immunoreceptor tyrosine-based
activation motifs (ITAMs) within the cytoplasmic domains of Igα
and Igβ to allow their phosphorylation by cytoplasmic protein
tyrosine kinases (PTKs)8,12. This ‘dissociation activation model’
of BCR signal initiation basically reversed the traditional concept,
according to which it is the antigen-induced clustering of pre-
dominantly monomeric BCR units that causes a local accumu-
lation of otherwise scattered ITAMs to allow their efﬁcient
phosphorylation by PTKs13–16.
However that may be, even in the absence of antigen the BCR
seems to send signals into the cell that are essential for the sur-
vival of mature B cells in vivo17–19. This poorly deﬁned survival
or maintenance signal is believed to reﬂect an antigen-
independent tonic activity of the BCR that may also involve a
crosstalk with other cell surface proteins such as the BAFF
receptor (also known as BR3) or Toll-like receptors20,21.
In addition to this very low level of tonic maintenance signal, a
constitutively elevated signaling activity of the BCR has been
reported to be involved in survival and probably also formation of
B cell-derived tumors, such as activated B cell-like diffuse large B
cell lymphoma (ABC DLBCL) or chronic lymphocytic leukemia
(CLL). Such chronically active BCR signaling can be brought
about by mutations that cause amino-acid substitutions in the
intracellular domains of Igβ or Igα in case of ABC DLBCL22 or by
auto-aggregation of BCRs in case of CLL23–25. CLL-derived Ig
variable (V) domain sequences are remarkably stereotypic and
have been shown to bind to self-epitopes in the V domains of
neighboring BCRs23,24,26–28. A single amino-acid substitution
within the self-epitope is sufﬁcient to completely abolish the
chronic signaling activity of CLL-derived BCRs23. Whether or not
such chronic BCRs adopt a different organization in the plasma
membrane than common, tonic BCRs with regard to clustering or
oligomerization remains unknown.
Here we use stimulated emission depletion (STED) and
dSTORM super-resolution microscopy techniques29 to investi-
gate the organization of native mIgM-containing BCRs with tonic
and chronic signaling activity in human B cells. We observe that
‘tonic’ BCRs exist primarily as monomeric and dimeric units on
the cell surface and form oligomeric clusters only when stimu-
lated. In contrast, a CLL-derived ‘chronic’ BCR predominantly
forms dimers and oligomers within the plasma membrane, which
is reverted by a single amino acid substitution in its binding
motif. In conclusion, our data reinforce the concept according to
which antigen binding induces clustering of mostly monomeric
BCR to initiate ITAM-controlled intracellular signaling reactions.
Results
A STED-based approach to determine the arrangement of
BCRs. To study the organization of native BCR complexes within
the plasma membrane, it is essential to put the utmost attention
to all technical details. Among all the most important details are
the characteristics of the molecular probes used to detect the
BCRs and the ﬁxative procedure to immobilize the BCR com-
plexes in the plasma membrane. Therefore, it was not only
necessary to use a monovalent detection reagent to avoid artiﬁcial
clustering of BCRs, but also to have a single ﬂuorophore per
afﬁnity probe to enable a quantitative assessment of ﬂuorescence
intensities. These features can be found in a group of small
recombinant proteins of ~7 kDa termed afﬁbodies30, which
typically bind to their targets (here human Ig µ heavy chain) with
high speciﬁcity and afﬁnity. Importantly, each afﬁbody molecule
has only a single cysteine residue, which allows the site-directed
conjugation of strictly one ﬂuorescent dye molecule per molecule
of afﬁbody. We made use of this advantage and coupled the anti-
human IgM afﬁbody to the ﬂuorophore Star635P (afﬁbody-
Star635P) to perform STED microscopy (for more details see
Methods). To test the speciﬁcity of the ﬂuorescently labeled
afﬁbody, we used Ramos B cells expressing endogenous mIgM-
containing BCRs and a mIgM-negative Ramos sub-line
(mIgMneg) and stained both cell types with the afﬁbody-
Star635P. The ﬂuorescently labeled afﬁbody had a clear speciﬁ-
city for mIgM-expressing cells (Supplementary Fig. 1a, b).
Importantly, the anti-IgM afﬁbody-Star635P did not induce
substantial activation of the BCR as assessed by intracellular Ca2+
mobilization (Supplementary Fig. 1c). The subtle signal that we
observed was most likely caused by traces of afﬁbody dimers that
can be formed during the ﬂuorophore conjugation reaction via
disulﬁde bonding of the single afﬁbody cysteines. These dimers
would be ﬂuorophore-free and thus would not contribute to the
ﬂuorescence signal.
Since every conjugated afﬁbody molecule was coupled to
exactly one ﬂuorophore molecule (degree of labeling was >97%),
this afﬁnity probe had a very homogeneous ﬂuorescence intensity
distribution that was determined by using STED microscopy on
afﬁbody-Star635P conjugates sparsely dispersed on glass cover-
slips (Supplementary Fig. 1e). We then tested whether we could
use this afﬁnity probe for quantitative imaging by incubating it
with a recombinant monomeric human IgM-Fc molecule (which
contains two Ig µ heavy chains) followed by STED microscopy as
before (Supplementary Fig. 1e). The average intensity from single
spots of monomeric IgM-Fc molecules incubated with Star635P-
labeled afﬁbodies was roughly 1.85 times brighter than that of
single-ﬂuorophore-labeled afﬁbodies (Supplementary Fig. 1f).
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-08677-1
2 NATURE COMMUNICATIONS |          (2019) 10:820 | https://doi.org/10.1038/s41467-019-08677-1 | www.nature.com/naturecommunications
This value is very close to the theoretical value of 2.0 times
higher31 and indicates that the majority of monomeric IgM-Fc
molecules can indeed accommodate two afﬁbody-Star635P
molecules. In addition, we used microscale thermophoresis to
determine the afﬁbody:IgM-Fc stoichiometry as previously
performed by Kazemier et al32. In agreement with our
previous experiments, also the thermophoresis analysis indicates
a 2:1 binding stoichiometry (afﬁbody:IgM-Fc; Supplementary
Fig. 1g, h).
Having established the speciﬁcity of the afﬁbody against
human IgM, its inability to activate the BCR and its suitability to
quantitatively detect IgM-Fc monomers, we ﬁnally determined
the saturating amount of afﬁbody-Star635P that was needed to
stain the cell surface pool of mIgM-containing BCRs on Ramos B
cells (Supplementary Fig. 1i).
Arrangement of mIgM-BCRs on the surface of human B cells.
We then used the exquisite (m)IgM-speciﬁc afﬁbody afﬁnity
probe to investigate the organization and distribution of mIgM-
containing BCRs on the cell surface of human B cells using STED
microscopy. To this end we incubated live B cells with saturating
amounts of ﬂuorophore-conjugated afﬁbody for 30 min on ice
to minimize steady-state endocytosis of labeled BCRs33. After
extensive washing, the cells were ﬁxed using ice-cold buffer
containing 4% paraformaldehyde (PFA) and 0.1% glutaraldehyde
(GA) for 30 min. As previously demonstrated by Tanaka et al.,
incubation with a combination of PFA and GA is essential to
effectively stop movement of membrane proteins34. Furthermore,
ice-cold conditions prevent ﬁxation-induced blebbing and swel-
ling artifacts35,36. Labeled and ﬁxed cells were allowed to sedi-
ment on glass coverslips and subsequently were exposed to a
single sonication pulse. This treatment removed cell bodies,
leaving on the coverslip intact plasma membrane patches that
were in direct contact with the glass surface (Fig. 1a). This
method to generate membrane sheets has been frequently used to
study the distributions of membrane lipids and integral mem-
brane proteins37–41. A major advantage of membrane sheets is
that any ﬂuorescence signal obtained by STED microscopy (or
any other microscopy technique) selectively comes from the
plasma membrane, thus minimizing signals from endocytosed
BCRs. Moreover, this setting provided an excellent signal-to-
noise ratio, which was required for observing single receptors.
Using this protocol, we imaged dozens of membrane sheets from
Ramos B cells and from primary human peripheral blood B cells
obtained from healthy donors (Fig. 1b and e, respectively). Both
primary B cells and Ramos B cells revealed the presence of dis-
crete spots of mIgM-BCRs on their surfaces.
The ﬂuorescence signal intensity distribution of the spots was
then analyzed and compared to the intensity distribution of single
ﬂuorescent afﬁbodies sparsely scattered on a coverslip, which was
performed as the reference control for single-ﬂuorophore inten-
sities in every imaging session (Fig. 1c, f). An algorithm was
created to ﬁnd spots in a manually selected area of the membrane
sheets (avoiding, for example, the borders of the membrane sheets
where often double bilayer membranes can be found). Spots were
ﬁrst localized and their intensity line proﬁles on X and Y axes were
ﬁtted to a Gaussian distribution. Spots were considered ‘true spots’
only if the quality of their ﬁts in X and Y was satisfactory and if
their sizes (full width at half maximum, FWHM) were smaller than
700 nm. Due to the resolution limit of our STED instrument it was
not possible to resolve any two spots closer than 50–60 nm. For
further analysis we used the integrated ﬂuorescence intensity
(in the following “intensity” always means integrated intensity) of
each spot to infer the number of ﬂuorophores. The ﬂuorescence
intensity distributions of the analyzed spots on the membrane
sheets were ﬁtted to a sum of Gaussian distributions for which the
center position of each Gaussian curve was forced to be multiples
of the center position determined by the single-ﬂuorophore
reference distribution (Supplementary Fig. 2a). From the ampli-
tude of these Gaussian distribution ﬁts, we derived the proportion
of what we deﬁne as apparent monomeric, dimeric, and oligomeric
mIgM-BCRs present in the B cell membrane sheets. Spots that
contain one or two ﬂuorescent afﬁbody molecules are deﬁned as
apparent mIgM monomers, those that contain three or four
afﬁbody copies are deﬁned as apparent mIgM dimers, and so forth
(for illustration see hypothetical analysis in Supplementary
Fig. 2b).
With this methodology and deﬁnition, roughly 56.7 ± 2.9%
(mean ± standard deviation) of the BCRs in the plasma
membrane of resting Ramos B cells represented apparent
monomeric mIgM molecules. About 31.8 ± 8.4% of the mIgM-
BCRs are consistent with dimers and only 10.9 ± 8.9% of them are
found in small oligomers (≥3 mIgM-BCRs molecules per spot)
(Fig. 1d, g and Supplementary Fig. 2a, c). Additionally, the
remaining large clusters of BCRs that were not considered by the
aforementioned ‘true-spot’ criteria were also considered by
calculating their percentage signal intensities in relation to
the total ﬂuorescence signal derived from a membrane sheet.
The signal contribution of these large clusters was calculated
and represented 0.56 ± 0.2% of the total signal present in the
membrane sheets (Fig. 1d, g). Noteworthy, the distribution
trends of mIgM-BCRs were similar for both Ramos and primary
human B cells. Please note that during the ﬂuorophore
conjugation reaction, smidgens of afﬁbody molecules may have
formed disulﬁde-bonded (non-ﬂuorescent) dimers, which cannot
efﬁciently be separated from the monomers due to their small
molecular weight difference. These afﬁbody dimers may have
caused some otherwise monomeric mIgM molecules to arrange in
higher ordered structures. However, the effect of such unintended
clustering is probably very limited.
To test whether the distribution of BCRs changes upon their
stimulation, we treated the cells with BCR-activating divalent
F(ab’)2 fragments speciﬁc to human (m)IgM (see Supplementary
Fig. 1c). As before, we incubated the cells on ice, since at higher
temperatures activated BCRs are rapidly internalized42–44, which
interferes with our microscopic analysis of mIgM molecules in
the plasma membrane. The kinetics of BCR-proximal signaling
processes as tested by Ca2+ mobilization are slightly decelerated
under these conditions, but remain similar to those at more
physiological temperatures (see Supplementary Fig. 1d). Hence,
this experimental condition appears a suitable approach to
stimulate BCRs while at the same time preventing their rapid
endocytosis. The ﬂuorescence intensities of mIgM-BCR-
containing spots on Ramos B cells were greatly enhanced when
the cells were exposed to this BCR-stimulating reagent, resulting
in a higher proportion of oligomers and clustered mIgM-BCRs
(Fig. 1h–j and Supplementary Fig. 2d). This observation is in
agreement with the notion that clustering of mostly monomeric
and dimeric BCRs is a crucial step in the activation of BCR
signaling. At any rate, we did not observe a dissociation of pre-
clustered oligomeric BCRs on addition of the stimulating reagent.
In addition, we tested whether our methodology can be used to
investigate the organization of mIgM-BCRs in native B cells using
monovalent Fab fragments, which are usually readily available for
most cell surface receptors. To this end we repeated the
experiments shown above with a Fab against human (m)IgM
coupled to the Star635P ﬂuorophore (Supplementary Fig. 3a–d).
As before, membrane sheets of Ramos B cells stained with the
anti-IgM Fab-Star635P probe displayed discrete spots and
ﬂuorescence intensity distributions similar to the ones obtained
with the afﬁbody-based afﬁnity probe (Supplementary Fig. 3e).
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Moreover, when the cells were activated with divalent F(ab’)2
fragments against human IgM, large clusters appeared together
with the characteristic shift in the ﬂuorescence intensity
distribution pattern (Supplementary Fig. 3f). Unfortunately, the
Fab-Star635P was not suitable to determine the organization of
mIgM-BCRs in a quantitative manner. This was mainly due to
the unknown number of ﬂuorophore molecules per Fab molecule
and the broad ﬂuorescence intensity distribution proﬁles when
analyzing single monomeric immunoglobulin µ heavy chains by
STED microscopy. Nonetheless, also with this staining strategy
we were not able to detect preformed oligomeric clusters of
mIgM-BCRs on the surface of resting B cells.
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Fig. 1 Arrangement of mIgM-containing BCRs in the plasma membrane of human B cells. a Schematic depiction of the staining procedure and the
generation of plasma membrane sheets. b, e, h Images of membrane sheets of unstimulated Ramos B cells (b), unstimulated primary B cells (e), and
Ramos cells stimulated with anti-IgM F(ab’)2 fragments for 30min on ice (h). Membrane sheets were stained with the membrane marker R18 (confocal
images pseudo-colored in green) and anti-human IgM afﬁbody-Star635P (STED images displayed in red). White squares on central images indicate
the zoomed regions that are displayed in the images to their right. Scale bars represent 5 µm and 1 µm for the low and high zoom images respectively.
c, f, i Example histograms showing the ﬂuorescence intensity distributions of single Star635P-conjugated afﬁbodies on coverslips (black curves, control)
and mIgM-spots present in membrane sheets (red curves, mIgM-BCRs). d, g, j Percentages of different mIgM-BCR arrangements in plasma membrane
sheets were calculated after pooling the spot intensities of dozens of membrane sheets together and then ﬁtting the intensity distribution to a sum
of Gaussian curves (Supplementary Fig. 2). Data were obtained from four and three independent experiments including a total of 30 membranes from
unstimulated and 15 membranes from F(ab’)2-stimulated Ramos B cells, respectively. The experiments with primary human B cells were performed
three independent times from two different donors and 30 membrane sheets were analyzed in total. Error bars represent the 68% conﬁdence interval,
corresponding to 1 standard deviation. Histogram’s source data are provided as a Source Data ﬁle
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Unstimulated mIgM-BCRs do not assemble in large islands.
Previous studies using dSTORM reported the existence of large
clusters (or islands) of mIgM-containing BCRs on the surface of
resting B cells with average diameters of either ~150 nm9 or
several hundred nm10, which would accommodate an average of
roughly 30–50 mIgM-BCRs9,10. To test whether this discrepancy
to our ﬁndings was due to the different imaging techniques used,
we employed dSTORM imaging to study the organization of
mIgM-BCRs on the surface of intact cells. For this purpose, we
stained Ramos B cells with the anti-IgM afﬁbody, this time
coupled to CFTM647 ﬂuorophores (afﬁbody-CF647, DOL 0.97,
Supplementary Fig. 4). dSTORM imaging could be performed
with intact cells due to the use of a total internal reﬂection
ﬂuorescence (TIRF) setup (Fig. 2a). The TIRF/dSTORM conﬁg-
uration allowed us to selectively image the proximal ~200 nm into
the sample from the glass coverslip45–47, which is several folds
better than the ~700 nm axial resolution of a confocal micro-
scope. This enabled us to super-resolve mIgM-BCRs in the
plasma membrane of intact B cells. After staining the cells with
saturated concentrations of ﬂuorescent afﬁbody (Supplementary
Fig. 4), the average FWHM of the spots present in the plasma
membrane was below 37 nm. However, the median of 31 nm
suggests that most of the spot sizes were actually smaller than the
average and very similar to the maximal average resolution of
36 nm achieved by imaging single CF647-labeled afﬁbodies on a
glass surface (Fig. 2c). Importantly, in our samples that were ﬁxed
with both PFA and GA, we detected only very few large clusters
(or islands) that were greater than 70 nm in diameter after
staining with ﬂuorescent afﬁbody. Although it is very difﬁcult to
be quantitative in dSTORM imaging due to several potential
artifacts that can lead to inaccurate results48–53, our observations
consistently suggest that mIgM-BCRs on the surface of unsti-
mulated B cells can be found in different molecular arrangements.
However, the majority of cell surface BCRs seems to be arranged
as monomers and dimers, but not in preformed large islands as
previously suggested.
Dimeric and oligomeric organization of a CLL-derived BCR.
Since the constitutive (or chronic) signaling status of BCRs has
been linked to tumor formation especially in CLL, we aimed to
employ our imaging strategy to investigate the molecular
arrangement of a CLL-derived BCR on the plasma membrane of
human B cells. Speciﬁcally, we wanted to address whether CLL-
derived BCR complexes show signs of auto-aggregation on the
cell surface, since the V region sequences of CLL-derived Ig heavy
chains have been shown to mediate autonomous chronic
activation of CLL-BCRs, most likely by interacting with epitopes
within the Ig heavy chain V (VH) regions of neighboring BCRs
on the same cell23,24.
To analyze the clustering status of CLL-derived BCRs, we
generated a cellular model system that allowed us to study a CLL-
BCR in a genetically tractable manner and a deﬁned cellular
context. To this end we cloned the V gene segment of the Ig light
(VL) locus from an unmutated CLL (U-CLL, for details see
Methods) sample and expressed it constitutively in a variant of
the human Burkitt lymphoma cell line DG75, which has lost
expression of its endogenous mIgM-BCR (mIgMneg). In addition,
we cloned the corresponding VH region from the same CLL
sample and expressed it in a doxycycline-inducible manner in the
context of a membrane-bound Ig µ heavy chain. To test our
expression system, we ﬁrst analyzed the levels of ‘CLL-derived’
mIgM on the cell surface by ﬂow cytometry (Supplementary
Fig. 5). Super-resolution STED microscopy was then used to
image membrane sheets of these cells as well as the parental
DG75 B cell line, which expresses an endogenous mIgM-BCR (of
unknown speciﬁcity). Analysis of the endogenous BCR of DG75
cells showed a very similar ﬂuorescence intensity distribution
proﬁle as observed in Ramos and primary B cells (see Fig. 1) with
67.6 ± 3% of the BCRs being apparent monomers and 29.8 ± 8.5%
corresponding to apparent dimers of mIgMs (Fig. 3a–c). Strik-
ingly, this ratio was inverted in DG75 cells expressing the CLL-
derived BCR (Fig. 3d–f), indicating that the CLL-derived Ig V
regions indeed caused auto-dimerization and oligomerization of
mIgM-BCRs on the cell surface. Additionally, a slight increase in
the number of larger clusters (4.01 ± 0.5%) was also observed in
cells expressing the CLL-derived BCRs (Fig. 3f).
To test whether the differences in the apparent dimer
formation between the tonic BCRs from primary and Burkitt
lymphoma B cells and the CLL-derived BCR are indeed caused by
autonomous self-aggregation of the latter, we replaced an arginine
residue within the CLL VH domain, which lies within a motif that
was reported23 to serve as ‘auto-antigen’ for chronic activation of
CLL-derived BCRs, with alanine (R38A) and analyzed this
mutant CLL-BCR as before. Indeed, this single amino acid
substitution fully reversed the auto-aggregation displayed by the
CLL-derived BCR and converted it into a mostly monomeric
receptor (Fig. 3g–i), showing that self-reactivity of this CLL-BCR
caused it to arrange as dimers and oligomers.
Discussion
Here we have shown that tonic mIgM-containing BCRs of pri-
mary human B cells are apparently organized as monomers and
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Fig. 2 mIgM-BCRs do not arrange in large protein islands at the plasma membrane. a Schematic depiction of the TIRF/dSTORM setup imaging depth.
b Representative TIRF/dSTORM image of an intact Ramos B cell stained with CFTM647-conjugated anti-IgM afﬁbodies. The dotted white trace delineates
the area of the plasma membrane close to the glass coverslip imaged under TIRF/dSTORM mode. The white square indicates the zoomed area shown in
the image to the right. Scale bars represent 1 µm and 0.5 µm for the low and high zoom, respectively. c Scatter plot displaying the spot size (FWHM)
distribution unstimulated Ramos cells and as resolution reference the scatter plot of single CFTM647- afﬁbodies spread on a glass coverslip
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dimers within the plasma membrane of resting cells, whereas a
CLL-derived chronic BCR tends to be organized as dimers and
oligomers, which is dependent on the presence of an intact
recognition motif within the Ig heavy chain V region of the CLL-
derived BCR. Previous reports using biochemical and indirect
visualization approaches suggested that BCRs on the surface of
resting cells might accommodate larger, oligomeric clusters,
which were hypothesized to adopt a closed, probably auto-
inhibiting conformation5,7,8,12. Also, independent studies using
dSTORM microscopy imaging approaches indicated the existence
of antigen-independent BCR oligomers on the B cell surface, even
though the results of these studies differed considerably9–11. With
our STED-based imaging method we did not detect such an
oligomeric organization of resting BCRs. This was not due to
technical limitations of our approach, since we were able to detect
large mIgM-BCR clusters following stimulation with a BCR-
activating divalent reagent. However, also our ﬂuorescence
intensity-based method has some intrinsic constraints. For
instance, our deﬁnition of apparent BCR monomers, dimers, and
oligomers may be complicated by a potential non-saturated
binding of the afﬁbody to (m)IgM molecules. Thus, our results
tend to have a slight bias towards smaller cluster sizes, since e.g., a
spot containing two ﬂuorophores would in our analysis be clas-
siﬁed as monomer, but theoretically could also be a dimer with
extremely poor (only 50%) labeling efﬁciency. Furthermore, the
ﬂuorescence intensity distribution proﬁles of ﬂuorescent spots
typically get broader with increasing brightness, which limits the
accuracy of our method to estimate the number of BCRs in spots
that are equivalent to approximately six or more ﬂuorophores.
Nevertheless, we did not observe a large proportion of bright
spots (≥6 ﬂuorophores) on resting B cells. In fact, the vast
majority of the spots we found in the plasma membranes of
resting cells displayed ﬂuorescence intensity distributions con-
sistent with monomeric and dimeric organization of BCRs.
Our novel imaging approach allowed us to visualize relatively
subtle changes in BCR clustering that were caused by auto-
aggregation of a chronic CLL-derived BCR in the absence of an
exogenous BCR crosslinker. Hence, our method can detect (oli-
gomeric) BCR clusters if they exist. This raises the question as to
why other groups have come to different results. One of the most
critical parameters that has to be treated with the utmost care is
the immobilization of membrane proteins during the ﬁxation step
to avoid any chance of lateral movement following staining of the
receptors. It has been demonstrated that poor ﬁxation (10 or even
30 min using 4% paraformaldehyde) will not stop membrane
proteins from lateral difusion34. Therefore, lateral diffusion of
insufﬁciently ﬁxed BCRs poses a major problem in the inter-
pretation of dSTORM images10,11,34. Our ﬁxation procedure,
which included a combination of ice-cold paraformaldehyde and
glutaraldehyde, was chosen to make sure that transmembrane
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Fig. 3 Cell surface arrangement of a CLL-derived mIgM-BCR. a, d, g Plasma membrane sheets of DG75 B cells (a), an mIgMneg variant expressing a CLL-
derived mIgM-BCR (CLL-BCR, d) or the R38A-mutant variant thereof (CLL-R38A-BCR, g) were analyzed as in Fig. 1. White squares indicate the zoomed
regions. Scale bars represent 5 µm for the low zoom images and 1 µm for the high zoom STED images. b, e, h Example histograms of the spot ﬂuorescence
intensities for each cell type. c, f, i Percentages of different mIgM-BCR arrangements were derived as in Fig. 1. Data were obtained from three independent
experiments including 16 membranes for DG75, 17 membranes for the CLL-BCR, and 12 membranes for the CLL-R38A-BCR (raw data in Supplementary
Fig. 5). Error bars represent the 68% conﬁdence interval, corresponding to 1 standard deviation. Histogram’s source data are provided as a Source Data ﬁle
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proteins are clearly immobilized before we prepared membrane
sheets for microscopic analyses34–36.
Furthermore—unlike indirect visualization strategies—our
approach is not biased since it does not require BCRs to be in
close proximity to be detected as is the case for the PLA or the
BiFC method, which both fail by design to detect monomeric
components and thus inevitably mask out the presence of
monomeric BCRs8,10. In line with our observations, a previous
study using Förster resonance energy transfer (FRET) experi-
ments could not provide evidence for the existence of BCR oli-
gomers in resting cells6. Interestingly, also the T cell antigen
receptor (TCR) was recently shown by a combination of different
super-resolution imaging approaches to exist predominantly as
randomly distributed monomeric units on the T cell surface54,55.
The STED microscopy technique takes advantage of control-
ling the transitions between on and off states of a ﬂuorophore in a
deﬁned space (pixel-by-pixel) while acquiring the image. This
results in a direct super-resolution image without the need of
complex data processing as is the case for localization techniques
like dSTORM56. Importantly, there are several known potential
artifacts that can be generated when imaging with single mole-
cular localization techniques. Some of such artifacts can be caused
by high density labeling, low irradiation power, and overcounting
localizations, all of which can strongly inﬂuence the size and
structure of the objects under investigation48–53. Another major
factor that allowed us to estimate the membrane organization of
BCRs was the use of afﬁbodies. Small and monovalent afﬁnity
probes like nanobodies, aptamers, or afﬁbodies are preferred as
accurate tools for current super-resolution microscopy
techniques29,57,58. Here we have used an afﬁbody against human
IgM, which is only ~7 kDa and ~2 nm in size and thus is superior
to e.g., antibodies in accessing epitopes. The monovalent binding
property of ﬂuorophore-conjugated afﬁbodies having only traces
of non-ﬂuorescent dimers minimizes the risk of inducing artiﬁcial
clustering of target molecules, allowing its incubation with live
cells prior to ﬁxation. Another unique feature of afﬁbodies, which
makes them ideal for quantitative imaging, is that they can be
conjugated with exactly one ﬂurophore molecule per afﬁbody in a
site-directed manner. We usually obtained between 0.97 and 0.99
moles of ﬂuorophores per mol of afﬁbody, which allowed stoi-
chiometric detection of endogenous levels of BCRs in cellular
membranes. This is typically not possible with other afﬁnity
probes like immunoglobulins or even Fab fragments that are
randomly conjugated to ﬂuorophores. Despite the small size of
afﬁbodies we cannot rule out that steric hindrance may have
caused incomplete labeling of large BCR clusters. Thus, even this
labelling strategy may not be ideally suited to determine the exact
number of receptors in large clusters.
Another factor that complicates the analysis of our spot
intensity histograms is that the mean and the width of the single-
ﬂuorophore-intensity distribution (SFID) are on the same order
of magnitude, and that the width of the peaks increases with the
number of ﬂuorophores per cluster (
ﬃﬃﬃ
n
p
, see formula in Meth-
ods). This leads to histograms with overlapping peaks that cannot
clearly be resolved by eye (see Suppl. Figures 2 and 5). Please note
that the width of the SFID has intrinsic reasons such as e.g., the
random distribution of the ﬂuorophores’ dipole orientations.
However, despite the overlapping peaks, we can still extract
robust information on the composition of cluster sizes from the
histograms by using the knowledge on the mean and the width of
the SFID, which we obtained from the single-ﬂuorophore cali-
bration measurements (Suppl. Figure 2a). Thus, only the ampli-
tudes of the peaks (an, see formula in Methods) are left to be
extracted from the ﬁts, thereby yielding robust results (indicated
by e.g., reasonably large R2 values and small conﬁdence intervals).
Nevertheless, we observed that the model did not always perfectly
ﬁt the experimental data (see Suppl. Figures 2 and 5). While part
of the deviations can be attributed to Poissonian number ﬂuc-
tuations, some deviations do not look purely statistical. These
deviations might be caused by instrument drift during imaging
sessions and/or the microenvironment of the ﬂuorophores being
slightly different in the plasma membrane as compared to the
conditions of the calibration measurements. Despite these small
imperfections, the ﬁt results are robust enough to support our
conclusions.
Stimulation of tonic BCRs with an activating reagent induced
formation of large clusters as anticipated by the crosslinking
model of BCR activation16. This observation does not concur
with recently proposed models according to which BCR stimu-
lation induces the dissociation of pre-clustered oligomeric BCRs
to initiate intracellular signaling. Instead, our results reinforce the
concept that antigen binding to many monomeric and dimeric
‘BCR units’ causes aggregation of ITAMs that in the absence of
antigen are dispersed in the plasma membrane. In this scenario
antigen functions as a classical adaptor molecule that connects
signaling components (here BCR complexes) that otherwise come
together only in a very inefﬁcient manner. This crosslinking of
BCRs might stabilize lipid-ordered domains in the plasma
membrane that facilitate BCR activation14,59. However, a con-
siderable pool of tonic mIgM-BCR spots contains apparent
receptor dimers and a small percentage seems to contain oligo-
mers already in the absence of antigen. The mechanisms that
cause dimerization of a large fraction of tonic surface mIgM-
BCRs remain to be investigated. However, it has been demon-
strated that the actin cytoskeleton controls the lateral movement
of BCRs by constituting barriers by which receptors are
immobilized14,15,20. Hence, dimers of tonic mIgM-BCRs may
reﬂect two monomeric BCRs that are trapped within a membrane
skeleton network compartment40,60, rather than being held
together by an intrinsic afﬁnity for each other. Nevertheless, it is
tempting to speculate that the dimeric or oligomeric pool of BCRs
provides the tonic maintenance signal of the BCR that has been
demonstrated in several mouse models to be critical for survival
of mature B cells17–19,61. If indeed the dimerization of tonic BCRs
is sufﬁcient to provide B cells with a survival signal, a relatively
moderate increase in the amount of BCR dimers and oligomers
that we observed for a CLL-derived BCR might be enough to tip
the balance toward chronic, pathological signaling.
We believe that our newly established quantitative STED-based
super-resolution microscopy approach will be a valuable method
to study the nanoscale organization of various immunoreceptors
not only in B cells and thus will be very useful to provide a better
understanding of the surface ‘landscape’ of immune cells and the
mechanisms that underlie immune receptor function.
Methods
Cells and expression vectors. The human Burkitt lymphoma B cell lines Ramos
and DG75 were purchased from the German Collection of Microorganisms and
Cell Cultures (DSMZ, Braunschweig, Germany). DG75EB cells expressing the
murine cationic amino-acid transporter 1, which makes them susceptible to
infection with MMLV-based retrovirus particles were described before62 and were
used in all experiments. Ramos and DG75EB cells lacking expression of endo-
genous mIgM were obtained by repetitive sorting of mIgM-negative cells identiﬁed
by staining with a polyclonal anti-human IgM antibody (SouthernBiotech,
Birmingham, USA). IgM-negative DG75EB cells were retrovirally transfected to
express a human λ Ig light chain derived from a patient CLL sample (#025). These
cells were additionally transfected with the doxycycline-controllable expression
vector pRetroX-TetOne™-Puro (Clontech Laboratories Inc., Montain View, USA),
encoding a human membrane-bound Ig µ (µm) heavy chain containing the vari-
able heavy (VH) region from CLL sample #025. The CLL #025 VH region is
composed of IGHV1-69, IGHD3-22, and IGHJ6, all of which are in germline
conﬁguration. The resulting CDR3 amino-acid sequence is CARFMDYYDSS-
GYYNPQYYYYGMDV (single letter code for amino acids). The arginine residue
at position 38 of the CLL#025 VH domain was replaced with alanine (R38A) by
site-directed mutagenesis. Primers used for this cloning and mutagenesis are in
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Supplementary Table 1. Expression of the CLL-derived µm heavy chain variants
was induced by addition of 5 µM doxycycline to the cells 18–24 h before staining.
All cell lines were cultured at 37 °C in a humid atmosphere with 5% CO2 in RPMI
1640 medium, (Gibco/Life Technologies, Carlsbad, USA or Biochrom, Berlin,
Germany), supplemented with 10% FBS (Biochrom, Berlin, Germany), 4 mM
L-glutamine and 100 U per ml each penicillin and streptomycin (Lonza, Basel,
Switzerland). Primary human B cells were isolated from peripheral blood of healthy
donors by a negative magnetic cell sorting strategy using the ‘B cell isolation kit II’
(Myltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer’s
instructions. The purity of the isolated B cells was assessed by staining of CD19 and
mIgM and was usually greater than 90%. Experiments involving human partici-
pants were approved by the ethical review committee of the University Medical
Center Göttingen and were performed in accordance with relevant guidelines and
regulations. An informed consent was obtained from all participants.
Flow cytometry and measurement of intracellular free Ca2+. Cell surface
expression of mIgM was analyzed by ﬂow cytometry using Alexa647-labeled poly-
clonal goat anti-human IgM antibodies (SouthernBiotech, Birmingham, Alabama,
USA). Data were acquired with a FACS Calibur or LSRII (BD Biosciences). Analysis
was done using FlowJo software (FlowJo, LLC, Ashland Oregon, USA). For analyzing
intracellular Ca2+ mobilization kinetics, 1 × 106 cells per measurement were
incubated in RPMI 1640 containing 10% FCS, 1 µM Indo-1-AM (Molecular Probes),
and 0.015% Pluronic-F-127 for 30min at 30 °C. The cells were then washed and
suspended in Krebs Ringer solution (10mM HEPES (pH 7.0), 140mM NaCl, 4 mM
KCl, 1 mM MgCl2, 1 mM CaCl2, and 10mM glucose). Basal Ca2+ levels were
measured for 30 s after which the cells were stimulated with the indicated reagents.
Measurements were done with a LSRII ﬂow cytometer (BD Biosciences) and data
analysis was done using FlowJo software (FlowJo, LLC) and Microsoft Excel. A
forward scatter/side scatter gate was used in all ﬂow cytometric analyses to identify
live cells and exclude cellular debris.
Conjugation of afﬁbodies or Fab to ﬂuorophores. Unconjugated anti-IgM afﬁ-
body® ab36088 (Abcam, Cambridge, UK) containing a single C-terminal cysteine
was coupled either to the maleimide variant of Star635P (Aberrior, Göttingen,
Germany) or to CFTM647 (Biotium, Fremont, USA) for STED and dSTORM
microscopy, respectively. Approximately 70 nmol of afﬁbody was incubated for
60 min at room temperature in 500 µl of reducing buffer (50 mM HEPES, 150 mM
NaCl, 10 mM EDTA, and 100 mM TCEP at pH 7.0). The reducing buffer including
TCEP was exchanged using a NAP5 desalting column (GE Healthcare), leaving the
reduced afﬁbody in argon-degassed 50 mM HEPES, 150 mM NaCl, 10 mM EDTA
at pH 7.6. The afﬁbody was immediately mixed with ~15 molar excess of the
maleimide ﬂuorophore to ensure that most if not all afﬁbodies were conjugated to a
ﬂuorophore. The coupling reaction was incubated at room temperature for 60 min.
Finally, cysteamine chloride was added (50 mM) for 15 min at room temperature to
quench remaining reactive ﬂuorophores. Fluorophore-conjugated afﬁbodies were
separated from free ﬂuorophores by using a self-packed desalting column with G-
25 superﬁne media (GE Healthcare, USA). The resulting degree of labeling (DOL)
was 0.99 mol of dye per mol of afﬁbody for the Star635P and 0.97 for the CFTM647.
The stock of Star635P-maleimide or CFTM647-maleimide were prepared in
anhydrous DMSO at a ﬁnal concentration of 10 µg per µl. Unconjugated Fab
fragment (0.5 mg) was brought to pH ~8.5 with 0.1 M NaHCO3 and incubated with
~8 molar excess of NHS-ester-Star635P for 60 min at room temperature under
constant agitation and protected from light. Remaining reactive dye was quenched
by adding excess of 1,5 M hydroxylamine at pH 8.5 and constant agitation for
30 more min. Finally, ﬂuorophore-conjugated Fab fragments were separated from
free ﬂuorophores by using a self-packed desalting column with G-25 sephadex
superﬁne media (GE Healthcare, USA). To determine the degree of labeling (DOL),
we ﬁrst determine the protein concentration in Molarity (M) as follow:
Prot: conc: Mð Þ ¼ A280  Amax ´CFð Þ
ε
ð1Þ
Where A280 is the absorbance at 280 nm, Amax is the absorbance value of the dye at
its maximal absorbance wavelength for the particular dye molecule. Correction
factor (CF) is a constant speciﬁc for each dye molecules to compensate the amount
of absorbance at 280 nm caused by the dye (information obtained from the dye
supplier). Finally, ε is the protein molar extinction coefﬁcient in M−1 cm−1.
Finally, to determine the DOL we need the molar extinction coefﬁcient of the
ﬂuorescent dye ε′ (information obtained by the dye supplier) and the following
equation.
DOL ¼ Amax ðof labeled proteinÞ
ε′ ´Prot: conc:ðMÞ ð2Þ
Staining of B cells with afﬁbodies or Fab. B cells (~200,000 per sample) were
centrifuged in 1.5 ml tubes for 4 min at 300 x g, and cell pellets were resuspended
with 50 µl ice-cold complete medium supplemented with ﬂuorescently labeled anti-
IgM afﬁbody or ﬂuorescently labeled Fab fragment. After incubation on ice for
30 min, cells were washed three times in ice-cold Dulbecco’s PBS (DPBS). After the
last washing step, the pellets were resuspended in 1 ml of ice-cold ﬁxation solution
composed of 4% paraformaldehyde and 0.1% glutaraldehyde in DPBS and trans-
ferred to one well of a 12-well plate containing poly-L-lysine- (PLL) coated cov-
erslips. The plate was centrifuged at ~100 x g for 10 min at 4 °C to allow the cells to
adhere to the coverslips. Plates were then incubated at room temperature in the
dark for 30 min. The ﬁxation solution was removed and 1 ml of quenching solution
composed of 0.1 M glycine in DPBS was added to each well. After 15 min of
quenching, cells were washed three times with DPBS. For whole cell imaging (e.g.,
Figure 3 and Supp. Figure 1 and 2) ﬁxed cells were additionally stained for 10 min
with 1 µg per ml of the membrane marker R18 (octadecyl rhodamine B chloride
from Molecular ProbesTM, Oregon, USA). After washing once with DPBS, cov-
erslips were either embedded for STED in Mowiol mounting media (6 g glycerol,
6 ml deionized water, 12 ml 0.2 M Tris buffer pH 8.5, 2.4 g Mowiol® 4–88, Merck
Millipore). For dSTORM imaging, coverslips were ﬁrst incubated with ﬂuorescent
beads (FluoSpheres®carboxylate-modiﬁed, 0.02 µm, crimson (625/645), diluted
1:1,000,000 in 0.1 mg ml−1 PLL) for drift correction. Afterwards, coverslips were
mounted using microscope slides with a cavity of ~15–18 mm in diameter and
0.6–0.8 mm in depth (Marienfeld Superior, Lauda-Königshofen, Germany, Cat
No. 1320002) in order to have the samples embedded in the buffer required for
dSTORM imaging. This buffer has a pH of 8.0 and is composed of 50 mM
Tris/HCl, 10 mM NaCl, 10 mM β-mercaptoethylamine (MEA), 10% glucose,
2000 U ml−1 catalase, 50 U ml−1 glucose oxidase, similar to what has been
described in earlier dSTORM studies63,64.
Generation of membrane sheets. Stained and ﬁxed cells (as described above)
were exposed to a brief and a single ultrasound pulse using a Sonopuls soniﬁer
HD2070 (Bandelin Electronic, Berlin, Germany). Coverslips containing the cells
were placed in the center of a glass container dish (Ø 95mm, Duran®, Carl Roth,
Germany) covered with ~150 ml of ice-cold sonication buffer (0.1 M glycin in
DPBS). The sonicator tip was positioned in the buffer at a distance of ~1 cm from
the coverslip and a one second ultrasound pulse with 10% power was applied. After
the sonication pulse coverslips were transferred to a 12-well plate containing DPBS
supplemented with 1 µg ml−1 of the membrane dye R18 (Molecular Probes,
Oregon, USA). After washing twice in DPBS, samples were embedded in Mowiol
and slides were stored at 4 °C protected from light until imaging the next day.
Induction of mIgM clustering. Live cells were stained on ice for 30 min with
ﬂuorophore-labeled afﬁbodies or Fab fragments as described above followed by
addition of 10 µg ml−1 of polyclonal goat anti-human IgM, Fc5µ fragment-speciﬁc
F(ab’)2 (Jackson ImmunoResearch, West Grove, PA, USA) or mouse anti-human
IgM mu chain monoclonal antibody ab99374 (1:100) (Abcam, Cambridge, UK)
for another 30 min on ice. All subsequent steps including washing, ﬁxation,
quenching, preparation of membrane sheets, and staining with R18 were done
as described above.
Reference signal from afﬁbodies or Fab fragment. Fluorophore-conjugated
afﬁbodies or Fab fragments were diluted 1:5000 in DPBS supplemented with 1%
bovine serum albumin (BSA) and seeded on poly-L-lysin- (PLL) treated glass
coverslips. After incubation for 1 h, coverslips were brieﬂy washed in a large
volume of ﬁltered DPBS (0.2 µm ﬁlter size) and ﬁnally mounted in Mowiol. These
samples were prepared and imaged in every imaging session and their spot
ﬂuorescence intensity distributions were used to calibrate the single-ﬂuorophore
intensities. Similarly, to determine the number of afﬁbodies that bound on average
to a single monomeric IgM molecule, 40 pmol of recombinant monomeric IgM-Fc
molecules (Absolute Antibody, catalogue # Pr00108-15.5) were incubated in
solution for 1 h at room temperature with 80 pmol of labeled anti-IgM afﬁbodies to
allow binding. To remove unbound labeled afﬁbodies, the mixture was further
incubated with 100 µl of high-capacity streptavidin-agarose beads (GE Healthcare)
preloaded with biotin-conjugated human pentameric IgM (Rockland Inc., Penn-
sylvania, catalogue # 009-0607) for 30 min at room temperature. After a short
centrifugation, the supernatant was incubated with a PLL-coated glass coverslip for
1 h, washed, mounted, and imaged as described above. To determine the number
of Fab fragments that bound on average to a single monomeric µ heavy chain
molecule, 1 nmol of puriﬁed µ chain (American Research Products Inc., catalogue
# 13-3035-2) was incubated in solution with 2–4 nmol of labeled Fab fragment for
1 h at RT. Complexes were then seeded on PLL-coated glass coverslips and incu-
bated for 1 h at room temperature. After a washing step using a large volume of
ﬁltered DPBS, coverslips were mounted in Mowiol.
Microscale Thermophoresis. The anti-IgM afﬁbody Kd was measured with a
NanoTemper Microscale Thermophoresis Monolith NT.115Pico (NanoTemper
Technologies GmbH, Munich, Germany). Five nsnomolar of afﬁbody-Star635P
was incubated with different concentrations (ranging from 0.05 to 1750 nM) of
recombinant IgM-Fc (Absolute Antibody, catalogue # Pr00108-15.5). All dilutions
were made using the MST buffer supplied together with the premium capillary by
the manufacturer. The curve ﬁtting and the Kd calculation were performed using
non-linear regression for binding saturation from GraphPad Prism. To determine
the stoichiometry of the interaction between IgM-Fc and afﬁbody a mixture of
5 nM of afﬁbody-635P and 395 nM of unlabeled afﬁbody was used to achieve
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-08677-1
8 NATURE COMMUNICATIONS |          (2019) 10:820 | https://doi.org/10.1038/s41467-019-08677-1 | www.nature.com/naturecommunications
saturating conditions, but not to saturate the detector of the microscale thermo-
phoresis device. The thermophoresis saturation point was determined using con-
centrations of recombinant IgM-Fc ranging from 18 to 1400 nM (16 points with
3:1 dilution). Linear regressions of the saturated and non-saturated data points
were performed as previously described by Kazemier et al32.
Imaging. A conventional epiﬂuorescence Olympus IX71 microscope equipped with
0.75 NA/60x oil objective and an Olympus F-View II CCD camera (Olympus,
Hamburg, Germany) was used for determining afﬁbody speciﬁcity and saturating
staining conditions (Supp. Figure 1,3, and 4). Confocal and STED images were
obtained with a True Confocal System STED SP5 ﬂuorescence microscope (Leica
Microsystems, Mannheim, Germany) equipped with a 100 × 1.4 NA PL APO CS
oil objective (Leica Microsystems, Mannheim, Germany). For confocal imaging
of membrane sheets stained with R18 (Figs 1 and 3 and Supplementary Fig. 3),
1024 × 1024 pixels images with a pixel size set to 50.5 and 20.2 nm, respectively,
were scanned at 1 kHz speed. Confocal signals were detected using a photo-
multiplier after Airy 1 pinhole size. Excitation of rhodamine dye (R18) was
performed with a 543 nm helium-neon laser line and the signal was detected
between 565 and 622 nm. Excitation of Star635P was done with a 633-nm helium-
neon laser and the signal was detected between 647 and 730 nm. For STED
imaging of (m)IgM molecules on membrane sheets and reference coverslips
(Figs. 1, 3 and Supplementary Fig 3), pixel size and scanning speed were set to
20.2 nm and 1 kHz, respectively, and the signal was detected with an avalanche
photodiode detector (APD). Excitation was performed with a 640 nm diode
laser and depletion with a MaiTai pulsed tunable laser at 750 nm (Mai Tai
Broadband, Spectra-Physics, Santa Clara, CA, USA). dSTORM images were
obtained with an Olympus IX83 ﬂuorescence microscope equipped with a x100
total internal reﬂection ﬂuorescence (TIRF) objective. CFTM647 ﬂuorophores were
excited in TIRF mode (penetration depth ~200 nm) using a 640 nm laser with a
total output power of 70 mW (Toptica iCHROME MLE multi laser engine),
resulting in a peak excitation intensity of ~2 kW per cm2. The exposure time was
set to 10 ms. Rhodamine dye (R18) was excited with a peak intensity of ~ 0.1 kW
per cm2 at 532 nm with an exposure time of 30 ms. The ﬂuorescence signal was
detected with an EMCCD camera (Andor iXON Ultra) using an EM-gain of 60 or
2 for CFTM647 and R18 detection, respectively. To separate the excitation light
from the emitted ﬂuorescence a Quadﬁlter was used, combined with a long-pass
ﬁlter (635LP) for the detection of CFTM647 and a bandpass ﬁlter (570/60) for R18.
For each dSTORM image 6000 frames were acquired from which the super-
resolution image was reconstructed. Prior to the actual acquisition a few hundred
frames were discarded during which the ﬂuorophores were transferred to the
dark state.
Data analysis and statistics. STED data analyses were performed with Matlab
(MathWorks Inc., Massachusetts, USA) using custom-written routines to deter-
mine spot sizes and intensities. The size and intensity of individual spots were
analyzed using an automated routine, as follows. Regions of interest (ROIs) within
the membrane sheets were deﬁned manually on the general membrane staining
(R18 channel), along with ROIs containing only background pixels (i.e., regions on
the coverslips that did not contain membrane sheets). To determine the spot
positions, the membrane sheet ROIs were subjected to a median ﬁlter, to remove
“salt-and-pepper” noise, and the positions of all remaining pixels (spots), whose
intensities surpassed the average background intensity by 10 arbitrary units were
determined. Gaussian curves were ﬁtted onto these pixels, relying on the raw data
images (not the median-ﬁltered). If X and Y Gaussian ﬁts suggest a true-spot, the
full width at half maximum (FWHM) and integrated intensity values presented
here were determined from these ﬁts.
For dSTORM, raw images were analyzed using the localization software
rapidSTORM65 and images were reconstructed using a custom-written Matlab
routine, which also allowed for drift correction by tracking ﬁducial markers.
The reconstructed images were then further analyzed using Matlab routines for
extracting the size and overall intensity (i.e., number of detection events) of the
CFTM647 spots by ﬁtting 2D Gaussian distributions.
The spot intensities obtained from the STED images of dozens of membrane
sheets where pooled together and the overall distributions were ﬁtted. As a ﬁt
model, we use the sum of Gaussian distributions, where we force the center
positions to be multiples of the center position of the single-ﬂuorophores reference
distribution
f Ið Þ ¼
X20
n¼1
an
1ﬃﬃﬃﬃﬃﬃﬃﬃ
2πn
p
σ
e
ðInI0 Þ2
2nσ2 ð3Þ
where I0 and σ are the center position and the width of the single-ﬂuorophore
intensity histogram, respectively (the upper limit of 20 ﬂuorophores is safely
beyond what we observe in the experiments). Thus, spots containing n
ﬂuorophores would result in an intensity distribution centered around nI0 with a
width of
ﬃﬃﬃ
n
p
σ. The amplitudes or weighting factors an are the parameters obtained
from the ﬁt and indicate the number of spots containing n ﬂuorophores.
The fraction of spots containing n ﬂuorophores is thus
fs;n ¼
anP20
n¼1 an
ð4Þ
The quantity we are interested in is the fraction of ﬂuorophores, which are part of
a spot containing n ﬂuorophores. This fraction is given by
ff ;n ¼
nanP20
n¼1 nan
ð5Þ
The two quantities fs,n and ff,n are also explained and depicted in the example
shown in Supplementary Fig. 2b. Since one receptor is typically labeled with two
ﬂuorophores the amplitudes for even numbers of ﬂuorophores are the dominant
contributions. We determined the fraction of ﬂuorophores, which label a monomer
as ff,1+ ff,2, i.e., every spot that contained one or two ﬂuorophores. Accordingly,
dimers of mIgM-BCRs contained three or four ﬂuorophores, and every spot
containing more than ﬁve ﬂuorophores was considered an oligomer. From the ﬁts
we obtained an for all amplitudes together with the respective conﬁdence intervals,
which was needed to determine the uncertainties of the monomer, dimer, and
oligomer fractions using standard rules for error propagation. To determine the
contribution of large clusters we ﬁrst calculated the proportion from the total signal
that was not monomers, dimers, and oligomers. Therefore, the rest of the signal
present in the membrane sheets correspond to large clusters that were not
considered true-spots due to their large size (≥700 nm FWHM) or inhomogeneous
shape (bad X & Y Gaussian ﬁts).
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The raw data underlying Figs. 1d, g, j and 3c, f, i and Supplementary Figs. 2 and 5b, c, d
are provided as a Source Data ﬁle. Custom-made Matlab codes can be obtained at
fopazo@gwdg.de.
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